Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

STSM 2025 & 2nd African Medical Writing Congress.

La Tunisie medicale·2026
Same author

Transforming breast cancer management with real-world data and artificial intelligence.

ESMO real world data and digital oncology·2026
Same author

PROMENADE: pembrolizumab for early ER-low/HER2-negative breast cancer, real-world French cohort.

ESMO open·2025
Same author

Impact of EGFR<sup>A289T/V</sup> mutation on relapse pattern in glioblastoma.

ESMO open·2022
Same author

[Securing the information system of health care organisations].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2022
Same author

Recommendations for stereotactic body radiation therapy for spine and non-spine bone metastases. A GETUG (French society of urological radiation oncolgists) consensus using a national two-round modified Delphi survey.

Clinical and translational radiation oncology·2022
Same journal

Comparative study of interstitial brachytherapy and intensity-modulated radiotherapy as tumour bed boost after conservative surgery for breast cancer: Toxicity and cosmetic outcomes.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Mar 17, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K

[Radiotherapy phase I trials' methodology: Features].

R Rivoirard1, A Vallard2, J Langrand-Escure2

  • 1Département d'oncologie médicale, institut de cancérologie de la Loire Lucien-Neuwirth, 108 bis, avenue Albert-Raimond, BP 60008, 42271 Saint-Priest-en-Jarez cedex, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|July 25, 2016
PubMed
Summary
This summary is machine-generated.

Biostatistical methods are crucial for clinical trial design, especially for phase I trials in radiotherapy and chemoradiotherapy. This study identifies shortcomings in current methodology to propose improved designs for future research.

Keywords:
ChemoradiotherapyChimioradiothérapieDosesMethodologyMéthodologiePhase IRadiotherapyRadiothérapieToxicitiesToxicité

More Related Videos

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Related Experiment Videos

Last Updated: Mar 17, 2026

Irradiator Commissioning and Dosimetry for Assessment of LQ &#945; and &#946; Parameters, Radiation Dosing Schema, and in vivo Dose Deposition
06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

7.8K
PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator
10:48

PET and MRI Guided Irradiation of a Glioblastoma Rat Model Using a Micro-irradiator

Published on: December 28, 2017

10.2K
Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
07:57

Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform

Published on: March 24, 2022

3.3K

Area of Science:

  • Clinical Research
  • Biostatistics
  • Oncology

Background:

  • Biostatistical methods are essential for rigorous data analysis in clinical research, guiding trial design from inception.
  • Established methodologies exist for chemotherapy and targeted therapy phase I trials focused on dose determination.
  • Phase I trials involving radiotherapy and chemoradiotherapy require methodologies that balance effectiveness and toxicity, yet literature is sparse.

Purpose of the Study:

  • To examine the characteristics of phase I radiotherapy and chemoradiotherapy trials.
  • To identify shortcomings in current methodological patterns for these specific trial types.
  • To propose novel and improved trial designs based on identified weaknesses.

Main Methods:

  • Focus on analyzing the specific characteristics of phase I radiotherapy and chemoradiotherapy trials.
  • Literature review to identify existing methodological patterns and their limitations.
  • Comparative analysis of methodologies across different treatment modalities.

Main Results:

  • Current literature provides limited data on the specific methodological designs for radiotherapy and chemoradiotherapy phase I trials.
  • Existing methodologies may not adequately address the dual endpoints of efficacy and toxicity in these complex treatments.
  • Shortcomings in current designs can lead to failures in subsequent trial phases.

Conclusions:

  • There is a critical need for more robust and tailored biostatistical methodologies for phase I radiotherapy and chemoradiotherapy trials.
  • Addressing identified methodological gaps can enhance trial success rates and optimize patient treatment.
  • Further research into advanced trial designs is warranted to improve the evaluation of novel radiation-based therapies.